Correction: ER
+
Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors
Clin Cancer Res
.
2019 Feb 15;25(4):1431.
doi: 10.1158/1078-0432.CCR-18-4270.
Authors
Angel L Guerrero-Zotano
,
Thomas P Stricker
,
Luigi Formisano
,
Katherine E Hutchinson
,
Daniel G Stover
,
Kyung-Min Lee
,
Luis J Schwarz
,
Jennifer M Giltnane
,
Monica V Estrada
,
Valerie M Jansen
,
Alberto Servetto
,
Joaquín Gavilá
,
J Alejandro Perez-Fidalgo
,
Ana Lluch
,
Antonio Llombart-Cussac
,
Mohamed Amine Bayar
,
Stefan Michiels
,
Fabrice André
,
Mónica Arnedos
,
Vicente Guillem
,
Amparo Ruiz-Simon
,
Carlos L Arteaga
PMID:
30770490
PMCID:
PMC6697080
DOI:
10.1158/1078-0432.CCR-18-4270
No abstract available
Publication types
Published Erratum
Grants and funding
K12 CA090625/CA/NCI NIH HHS/United States
L30 CA199438/CA/NCI NIH HHS/United States